Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72. doi: 10.1073/pnas.0705036104. Epub 2007 Nov 14.

Abstract

Having a parent affected with late-onset Alzheimer's disease (AD) is a risk factor for developing AD among cognitively normal subjects. We examined whether cognitively normal subjects with a parental family history of AD show cerebral metabolic rate of glucose (CMRglc) reductions consistent with AD as compared with those without a family history and whether there are parent gender effects. Forty-nine 50- to 80-year-old normal subjects were examined who received clinical, neuropsychological, and 2-[(18)F]fluoro-2-deoxy-d-glucose-positron emission tomography examinations, including 16 subjects with a maternal (FHm) and eight with a paternal (FHp) family history of AD and 25 with no family history (FH(-)). FH groups were comparable for demographic and neuropsychological measures. As compared with both FH(-) and FHp groups, FHm subjects showed CMRglc reductions in the same regions as clinically affected AD patients, involving the posterior cingulate cortex/precuneus, parietotemporal and frontal cortices, and medial temporal lobes (P < 0.05, corrected for multiple comparisons). These effects remained significant after accounting for possible risk factors for AD, including age, gender, education, apolipoprotein E genotype, and subjective memory complaints. No CMRglc differences were found between FHp and FH(-) subjects. This study shows a relationship between reduced CMRglc in AD-vulnerable brain regions and a maternal family history of AD in cognitively normal individuals.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Apolipoprotein E4 / genetics
  • Brain Mapping
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / metabolism*
  • Female
  • Fluorine Radioisotopes / pharmacokinetics
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Genes, Mitochondrial
  • Genetic Heterogeneity
  • Genetic Predisposition to Disease
  • Genomic Imprinting*
  • Glucose / metabolism*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Mothers
  • Positron-Emission Tomography*
  • Retrospective Studies
  • Risk

Substances

  • Apolipoprotein E4
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18
  • Glucose